WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 5 fonti

New Study Links GLP-1s to Hair Loss

Absolute risk of alopecia was low, however

Raccontata damedpagetoday.comindependent.co.ukmedicalxpress.comsciencealert.comirishtimes.com

Confronto fonti

5 prospettive sulla stessa storia
AI · summaries
medpagetoday.comStai leggendo18 h fa

New Study Links GLP-1s to Hair Loss

Absolute risk of alopecia was low, however

originale
medicalxpress.com12 h fa

GLP-1 diabetes drugs linked to up to 68% higher hair loss risk

The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ…

Leggi questa versione → originale
independent.co.uk12 h fa

Weight loss drugs linked to loss of hair in major new study

The study looked at 50,000 people on the drugs

Leggi questa versione → originale
irishtimes.com2 h fa

Weight-loss drugs linked to increased risk of hair loss, researchers say

People on GLP-1 agonist drugs such as Mounjaro, Ozempic and Wegovy have been reporting hair loss

Leggi questa versione → originale
sciencealert.com12 h fa

Common Weight Loss Drugs Have Been Linked to a Higher Risk of Hair Loss

GLP-1 drugs such as Wegovy and Ozempic have been revolutionary for obesity and type 2 diabetes treatments, but questions remain about some of the side effects and potential negative impacts of these medications.

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 22 luglio 2026·medpagetoday.com

    New Study Links GLP-1s to Hair Loss

    Absolute risk of alopecia was low, however

  2. giovedì 23 luglio 2026·independent.co.uk

    Weight loss drugs linked to loss of hair in major new study

    The study looked at 50,000 people on the drugs

  3. giovedì 23 luglio 2026·medicalxpress.com

    GLP-1 diabetes drugs linked to up to 68% higher hair loss risk

    The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type…

  4. giovedì 23 luglio 2026·sciencealert.com

    Common Weight Loss Drugs Have Been Linked to a Higher Risk of Hair Loss

    GLP-1 drugs such as Wegovy and Ozempic have been revolutionary for obesity and type 2 diabetes treatments, but questions remain about some of the side effects and potential…

  5. giovedì 23 luglio 2026·independent.co.uk

    Weight loss drugs tied to unexpected side effect, study finds

    Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged…

  6. giovedì 23 luglio 2026·irishtimes.com

    Weight-loss drugs linked to increased risk of hair loss, researchers say

    People on GLP-1 agonist drugs such as Mounjaro, Ozempic and Wegovy have been reporting hair loss